pEZYegfp Citations (9)

Originally described in: An in vitro recombination method to convert restriction- and ligation-independent expression vectors.
Guo F, Chiang MY, Wang Y, Zhang YZ Biotechnol J. 2008 Mar . 3(3):370-7. PubMed Journal

---

Articles Citing pEZYegfp

Articles
The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors. Sakai R, Fukuda R, Unida S, Aki M, Ono Y, Endo A, Kusumi S, Koga D, Fukushima T, Komada M, Okiyoneda T. J Cell Sci. 2019 Feb 7;132(3). pii: jcs.228007. doi: 10.1242/jcs.228007. PubMed
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer. Woolston A, Khan K, Spain G, Barber LJ, Griffiths B, Gonzalez-Exposito R, Hornsteiner L, Punta M, Patil Y, Newey A, Mansukhani S, Davies MN, Furness A, Sclafani F, Peckitt C, Jimenez M, Kouvelakis K, Ranftl R, Begum R, Rana I, Thomas J, Bryant A, Quezada S, Wotherspoon A, Khan N, Fotiadis N, Marafioti T, Powles T, Lise S, Calvo F, Guettler S, von Loga K, Rao S, Watkins D, Starling N, Chau I, Sadanandam A, Cunningham D, Gerlinger M. Cancer Cell. 2019 Jul 8;36(1):35-50.e9. doi: 10.1016/j.ccell.2019.05.013. PubMed
A systems mechanism for KRAS mutant allele-specific responses to targeted therapy. McFall T, Diedrich JK, Mengistu M, Littlechild SL, Paskvan KV, Sisk-Hackworth L, Moresco JJ, Shaw AS, Stites EC. Sci Signal. 2019 Sep 24;12(600). pii: 12/600/eaaw8288. doi: 10.1126/scisignal.aaw8288. PubMed
The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner. Ikeuchi M, Yuki R, Saito Y, Nakayama Y. FASEB J. 2021 Jan;35(1):e21242. doi: 10.1096/fj.202001909R. PubMed
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis. Kantar D, Mur EB, Mancini M, Slaninova V, Salah YB, Costa L, Forest E, Lassus P, Geminard C, Boissiere-Michot F, Orsetti B, Theillet C, Colinge J, Benistant C, Maraver A, Heron-Milhavet L, Djiane A. Sci Rep. 2021 Mar 11;11(1):5752. doi: 10.1038/s41598-021-85056-1. PubMed
De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies. Manivannan SN, Roovers J, Smal N, Myers CT, Turkdogan D, Roelens F, Kanca O, Chung HL, Scholz T, Hermann K, Bierhals T, Caglayan HS, Stamberger H, Mefford H, de Jonghe P, Yamamoto S, Weckhuysen S, Bellen HJ. Brain. 2022 Jun 3;145(5):1684-1697. doi: 10.1093/brain/awab409. PubMed
Uveal melanoma-associated mutations in PLCbeta4 are constitutively activating and promote melanocyte proliferation and tumorigenesis. Phan HTN, Kim NH, Wei W, Tall GG, Smrcka AV. Sci Signal. 2021 Dec 14;14(713):eabj4243. doi: 10.1126/scisignal.abj4243. Epub 2021 Dec 14. PubMed
Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach. McFall T, Stites EC. Cell Rep. 2021 Dec 14;37(11):110096. doi: 10.1016/j.celrep.2021.110096. PubMed
A naturally occurring membrane-anchored Galphas variant, XLalphas, activates phospholipase Cbeta4. Phan HTN, Loomis J, Abraham S, He Q, Bastepe M, Smrcka AV. J Biol Chem. 2022 Aug;298(8):102134. doi: 10.1016/j.jbc.2022.102134. Epub 2022 Jun 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.